Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

The prognosis in advanced-stage ovarian cancer remains poor. Tumor-specific intraoperative fluorescence imaging may improve staging and debulking efforts in cytoreductive surgery and thereby improve prognosis. The overexpression of folate receptor-α (FR-α) in 90–95% of epithelial ovarian cancers prompted the investigation of intraoperative tumor-specific fluorescence imaging in ovarian cancer surgery using an FR-α–targeted fluorescent agent. In patients with ovarian cancer, intraoperative tumor-specific fluorescence imaging with an FR-α–targeted fluorescent agent showcased the potential applications in patients with ovarian cancer for improved intraoperative staging and more radical cytoreductive surgery.

[1]  J. Affeldt,et al.  The feasibility study , 2019, The Information System Consultant’s Handbook.

[2]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  P. Low,et al.  Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  H. Ngan,et al.  FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancers , 2000 .

[5]  H. Ngan,et al.  FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  J. Reddy,et al.  Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical. , 2002, Bioconjugate chemistry.

[7]  P. Low,et al.  Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors , 2002, Cancer Immunology, Immunotherapy.

[8]  P. Low,et al.  Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. , 2003, Journal of biomedical optics.

[9]  B. Rice,et al.  Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. , 2004, Molecular imaging.

[10]  P. Low,et al.  Folate receptor-targeted drugs for cancer and inflammatory diseases. , 2004, Advanced drug delivery reviews.

[11]  P. Low,et al.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. , 2005, Analytical biochemistry.

[12]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[13]  W. Oyen,et al.  Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies , 2006, Annals of surgery.

[14]  W. Cliby,et al.  Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer , 2006, Obstetrics and gynecology.

[15]  L. Hartmann,et al.  Current management strategies for ovarian cancer. , 2007, Mayo Clinic proceedings.

[16]  Jan Grimm,et al.  A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.

[17]  S. Rubin,et al.  Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Low,et al.  Tumor detection using folate receptor-targeted imaging agents , 2008, Cancer and Metastasis Reviews.

[19]  Milton V. Marshall,et al.  Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.

[20]  David A Boas,et al.  Assessing the future of diffuse optical imaging technologies for breast cancer management. , 2008, Medical physics.

[21]  A. Meining,et al.  Highly sensitive detection of early‐stage pancreatic cancer by multimodal near‐infrared molecular imaging in living mice , 2008, International journal of cancer.

[22]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[23]  Kathryn E. Luker,et al.  Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.

[24]  Vasilis Ntziachristos,et al.  Multispectral imaging using multiple-bandpass filters. , 2008, Optics letters.

[25]  P. Low,et al.  Folate receptor alpha as a tumor target in epithelial ovarian cancer. , 2008, Gynecologic oncology.

[26]  M. Werner,et al.  Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. , 2008, Anticancer research.

[27]  Aya Nakagawa,et al.  Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. , 2008, American journal of surgery.

[28]  L. Senelick.  It (review) , 2008 .

[29]  A. Schneeweiss,et al.  Exploratory phase II efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse , 2008 .

[30]  I Vergote,et al.  Timing of debulking surgery in advanced ovarian cancer , 2008, International Journal of Gynecologic Cancer.

[31]  Vasilis Ntziachristos,et al.  Real-time intraoperative fluorescence imaging system using light-absorption correction. , 2009, Journal of biomedical optics.

[32]  F. Bray,et al.  Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  L. Ngo,et al.  The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping , 2009, Annals of Surgical Oncology.

[34]  P. Low,et al.  Strategy to Prevent Drug-Related Hypersensitivity in Folate-Targeted Hapten Immunotherapy of Cancer , 2009, The AAPS Journal.

[35]  R. Bristow,et al.  Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer: A Review , 2009, International Journal of Gynecologic Cancer.

[36]  P. Low,et al.  The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer , 2011, Cellular Oncology.

[37]  Jérôme Hugues,et al.  Model‐Based Analysis , 2013 .